We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Most eyes with keratoconus or corneal ectasia after ...

Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

Keratoconus is a rare, progressive ophthalmic disorder characterized by changes to the cornea that result in significant ...

Commercial rollout includes direct purchasing and specialty distribution, alongside scaled investments in awareness, ...

Glaukos Corporation GKOS recently announced the commercial availability of Epioxa, marking a significant milestone in its corneal health portfolio. The therapy stands out as the first FDA-approved, ...